Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Abnormal prothrombin (APT) ELISA Kit

Antigen

Abnormal prothrombin (APT)

Reactivity
Alternatives

Human

Application
ELISA
Certificates ISO 9001:2008
Catalog no. ABIN367003
Quantity 96 Tests
Price 990.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 7 to 10 Business Days

Additional Information

Characteristics This immunoassay kit allows for the in vitro quantitative determination of human APT concentrations in cell culture supernates, serum, plasma and other biological fluids.
Specificity This assay recognizes recombinant and natural human APT. No significant cross-reactivity or interference was observed.
Sensitivity The minimum detectable dose of human APT is typically less than 3 mAU/ml. The sensitivity of this assay, or Lower Limit of Detection (LLD) was defined as the lowest protein concentration that could be differentiated from zero. Detection Range: The minimum detectable dose of human APT is typically less than 3 mAU/ml. The sensitivity of this assay, or Lower Limit of Detection (LLD) was defined as the lowest protein concentration that could be differentiated from zero.

Application Details

Principle The microtiter plate provided in this kit has been pre-coated with an antibody specific to APT. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated monoclonal antibody preparation specific for APT and incubated. Then substrate solutions are added to each well. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of APT in the samples is then determined by comparing the O.D. of the samples to the standard curve.
Protocol Assay Procedure:
Bring all reagents and samples to room temperature before use. It is recommended that all samples, standards, and controls be assayed in duplicate. 5 1. Set a Blank well without any solution. 2. Add 5 0μl of Standard or Sample per well. Cover with the adhesive strip. Incubate for 20 min at 37° C. 3. Aspirate each well and wash, repeating the process three times for a total of three washes. Wash by filling each well with ddH 2 O (20 0μl) using a squirt bottle, multi-channel pipette, manifold dispenser or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining solution by aspirating or decanting. Invert the plate and blot it against clean paper towels. 4. Add 50 μl of HRP-conjugate solution to each well. Not to Blank ! Cover the microtiter plate with a new adhesive strip. Incubate for 20 min at 37°C. 5. Repeat the aspiration and wash three times as before. 6. Add 50 μl of Substrate A and 5 0μl of Substrate B to each well. Incubate for 15 minutes at 37°C. Keeping the plate away from drafts and other temperature fluctuations in the dark. 7. Add 50 μl of Stop Solution to each well. If color change does not appear uniform, gently tap the plate to ensure thorough mixing. 8. Determine the optical density of each well within 30 minutes, using a microplate reader set to 450 nm.
Calculation of Results:
Average the duplicate readings for each standard, control, and sample and 6 subtract the average zero standard optical density. Create a standard curve by reducing the data using computer software capable of generating a four parameter logistic (4-PL) curve-fit. As an alternative, construct a standard curve by plotting the mean absorbance for each standard on the y-axis against the concentration on the x-axis and draw a best fit curve through the points on the graph. The data may be linearized by plotting the log of the APT concentrations versus the log of the O.D. and the best fit line can be determined by regression analysis. This procedure will produce an adequate but less precise fit of the data. If samples have been diluted, the concentration read from the standard curve must be multiplied by the dilution factor.
Limitations of the Procedure:
The kit should not be used beyond the expiration date on the kit label.Do not mix or substitute reagents with those from other lots or sources.Any variation in operator, pipetting technique, washing technique, incubation time or temperature, and kit age can cause variation in binding.This assay is designed to eliminate interference by soluble receptors, binding proteins, and other factors present in biological samples. Until all factors have been tested in the Immunoassay, the possibility of interference cannot be excluded. 7.
Sample collection and storage:
Serum Use a serum separator tube (SST) and allow samples to clot for 30 minutes before centrifugation for 15 minutes at 1000 x g. Remove serum and assay immediately or aliquot and store samples at -20° C. Avoid repeated freeze-thaw cycles. Plasma Collect plasma using citrate, EDTA, or heparin as an anticoagulant. Centrifuge for 15 minutes at 1000 x g within 30 minutes of collection. Assay immediately or aliquot and store samples at-20°C. Avoid repeated freeze-thaw cycles. Note: Grossly hemolyzed samples are not suitable for use in this assay. If samples generate values higher than the highest standard, dilute the samples with the Sample Diluent and repeat the assay.
Application Notes When mixing or reconstituting protein solutions, always avoid foaming. To avoid cross-contamination, change pipette tips between additions of each standard level, between sample additions, and between reagent additions. Also, use separate reservoirs for each reagent. When using an automated plate washer, adding a 30 second soak period following the addition of wash buffer, and/or rotating the plate 180 degrees between wash steps may improve assay precision. To ensure accurate results, proper adhesion of plate sealers during incubation steps is necessary. Substrate Solution should remain colorless until added to the plate. Keep Substrate Solution protected from light. Substrate Solution should change from colorless to gradations of blue. Stop Solution should be added to the plate in the same order as the Substrate Solution. The color developed in the wells will turn from blue to yellow upon addition of the Stop Solution. Wells that are green in color indicate that the Stop Solution has not mixed thoroughly with the Substrate Solution.
Components Reagent (Quantity): Assay plate (1), Standard 6x1ml HRP-conjugate (1x6ml), Sample Diluent 1 x11ml Substrate A (1x7ml), Substrate B (1x7ml), Stop Solution (1x7ml)
Material not included Microplate reader capable of measuring absorbance at 450 nm, with the correction wavelength set at 540 nm or 570 nm. Pipettes and pipette tips. Deionized or distilled water. Squirt bottle, manifold dispenser, or automated microplate washer.
Storage 1. Unopened test kits should be stored at 2-8 C upon receipt and the microtiter plate should be kept in a sealed bag with desiccants to minimize exposure to damp air. The test kit may be used throughout the expiration date of the kit. Refer to the package label for the expiration date. 2. Opened test kits will remain stable until the expiring date shown, provided it is stored as prescribed above. 3. A microtiter plate reader with a bandwidth of 10 nm or less and an optical density range of 0-3 OD or greater at 450nm wavelength is acceptable for use in absorbance measurement.
Restrictions For Research Use only

Alternatives

Alternatives for antigen "Abnormal prothrombin (APT)", type "Kits"
Reactivities Human (1)